CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVAC CureVac B.V.

交易中 12-15 15:00:36 EST

5.04

-0.01

-0.30%

最高5.06	最低4.98	成交量113.74万
今开5.04	昨收5.05	日振幅1.44%
总市值11.34亿	流通市值6.34亿	总股本2.25亿
成交额571.24万	换手率0.90%	流通股本1.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVAC","market":"US","secType":"STK","nameCN":"CureVac B.V.","latestPrice":5.035,"timestamp":1765828776007,"preClose":5.05,"halted":0,"volume":1137381,"delay":0,"floatShares":125869472,"shares":225172749,"eps":0.936486,"marketStatus":"交易中","change":-0.015,"latestTime":"12-15 15:00:36 EST","open":5.04,"high":5.055,"low":4.9825,"amount":5712444.890355,"amplitude":0.014356,"askPrice":5.04,"askSize":3697,"bidPrice":5.03,"bidSize":3297,"shortable":3,"etf":0,"ttmEps":0.936486,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"listingDate":1597377600000,"exchange":"NASDAQ","adjPreClose":5.05,"preHourTrading":{"tag":"盘前","latestPrice":5.28,"preClose":5.05,"latestTime":"08:00 EST","volume":8,"amount":42.24,"timestamp":1765803606863},"postHourTrading":{"tag":"盘后","latestPrice":5.05,"preClose":5.05,"latestTime":"18:48 EST","volume":54,"amount":278.2,"timestamp":1765583310665},"volumeRatio":1.804333,"impliedVol":1.3475,"impliedVolPercentile":0.644},"requestUrl":"/m/hq/s/CVAC","defaultTab":"news","newsList":[{"id":"1174710771","title":"BioNTech建议CureVac股东在2025年12月2日星期二东部时间下午6点前递交其股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1174710771","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174710771?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:48","pubTimestamp":1764161321,"startTime":"0","endTime":"0","summary":"11月26日 - BioNTech SE宣布，CureVac于2025年11月25日举行的特别股东大会上批准了与其公开收购（“要约”）有关的事项，涉及CureVac N.V.（NASDAQ：CVAC，简称“CureVac”）的所有已发行股票。CureVac的股东被建议在2025年12月2日星期二东部时间下午6点之前递交他们的股票。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVAC","BK4585","BK4548","BK4139","BNTX","BK4588","BK4568","BK4551","BK4535"],"gpt_icon":0},{"id":"1110169712","title":"Curevac重申其预期现金流可持续至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1110169712","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110169712?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:24","pubTimestamp":1763987068,"startTime":"0","endTime":"0","summary":"2025年11月24日 - CureVac B.V.（CUREVAC NV）发布了第三季度的财报，第三季度收入为5410万欧元，超过IBES预估的334万欧元。同时，第三季度的息税前利润（EBIT）为3.102亿欧元。CureVac B.V.重申其预计的现金流将持续至2028年。此外，德国联邦反垄断局已批准BioNTech SE与CureVac的交易。在截至2025年9月30日的三个和九个月中，CureVac B.V.的净财务结果分别为260万欧元的亏损和220万欧元的利润。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4568","BK4551","BK4139","BK4548","BK4535","BNTX","CVAC","BK4588"],"gpt_icon":0},{"id":"1130262074","title":"CureVac B.V. - 截至2025年9月30日的三个月和九个月净财务结果分别为亏损260万欧元和盈利220万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130262074","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130262074?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:14","pubTimestamp":1763986452,"startTime":"0","endTime":"0","summary":"CureVac B.V. - 截至2025年9月30日的三个月和九个月净财务结果分别为亏损260万欧元和盈利220万欧元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","CVAC","BK4548","BK4139"],"gpt_icon":0},{"id":"1178732043","title":"德国联邦卡特尔办公室批准BioNTech SE收购CureVac B.V.","url":"https://stock-news.laohu8.com/highlight/detail?id=1178732043","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178732043?lang=zh_cn&edition=full","pubTime":"2025-10-14 16:51","pubTimestamp":1760431913,"startTime":"0","endTime":"0","summary":"德国联邦卡特尔办公室宣布，已批准BioNTech SE对CureVac B.V.的收购交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4139","BNTX","BK4568","BK4588","BK4551","BK4535","CVAC","BK4585"],"gpt_icon":0},{"id":"2557417475","title":"CureVac与辉瑞/BioNTech专利纠纷达成和解  葛兰素史克(GSK.US)获高额赔偿","url":"https://stock-news.laohu8.com/highlight/detail?id=2557417475","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557417475?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:51","pubTimestamp":1754643094,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1400636574.HKD","LU1046248800.SGD","BK4534","BK5011","BK4548","LU1202635105.USD","BK4533","159646","LU1400636491.USD","GSK.UK","LU1481599808.USD","LU1645745479.HKD","LU0109981661.USD","LU1228905037.USD","LU0456855351.SGD","LU1015430645.USD","LU1035777561.USD","LU1400636657.SGD","SG9999013999.USD","LU0321505868.SGD","BK4139","LU1066051498.USD","BK4551","LU0203347892.USD","LU0306807586.USD","CVAC","GSK","LU1829250122.USD","LU1023059063.AUD","SG9999001176.SGD","IE000M9KFDE8.USD","LU1098665638.USD","SG9999001176.USD","SGXZ57979304.SGD","BK4535","LU0971552830.HKD","LU1302929846.USD","BNTX","SG9999002224.SGD","BK4550","LU0122379950.USD","IE0002270589.USD","BK4568","BK4585","LU0225771236.USD","SG9999002232.USD","LU0203345920.USD","PFE","IE00B19Z3581.USD","159837"],"gpt_icon":0},{"id":"2550366020","title":"Curevac N.V.7月9日成交额为541.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550366020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550366020?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:45","pubTimestamp":1752111915,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Curevac N.V.成交额为541.88万美元，成交额较昨日增加53.91%，当日成交量为99.42万股。Curevac N.V.于2025年7月9日涨1.48%，报5.5美元，该股过去5个交易日涨1.66%，年初至今涨61.29%，过去60日涨92.31%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710094523a4416618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710094523a4416618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1829250122.USD","BK4588","BK4532","BK4548","BK4585","GSK.UK","BK4007","GSK","BK4551","CVAC"],"gpt_icon":0},{"id":"2549577567","title":"Curevac N.V.7月7日成交额为478.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549577567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549577567?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:43","pubTimestamp":1751938985,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，Curevac N.V.成交额为478.86万美元，成交额较昨日增加17.56%，当日成交量为88.36万股。Curevac N.V.于2025年7月7日跌0.73%，报5.41美元，该股过去5个交易日涨0.56%，年初至今涨58.65%，过去60日涨98.9%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708094313a43cda86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708094313a43cda86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","LU1829250122.USD","BK4532","GSK","BK4551","GSK.UK","CVAC","BK4139","BK4548","BK4007"],"gpt_icon":0},{"id":"2548332000","title":"Curevac N.V.7月3日成交额为407.32万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548332000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548332000?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:43","pubTimestamp":1751593435,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Curevac N.V.成交额为407.32万美元，成交额较昨日增加15.16%，当日成交量为75.10万股。Curevac N.V.于2025年7月3日涨0.93%，报5.45美元，该股过去5个交易日涨0.93%，年初至今涨59.82%，过去60日涨105.66%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704094357a4ce5ae1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704094357a4ce5ae1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4532","BK4007","BK4588","BK4585","BK4551","CVAC","GSK.UK","LU1829250122.USD","GSK","BK4139"],"gpt_icon":0},{"id":"2548858706","title":"Curevac N.V.7月1日成交额为608.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548858706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548858706?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:42","pubTimestamp":1751420568,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Curevac N.V.成交额为608.02万美元，成交额较昨日增加13.27%，当日成交量为112.38万股。Curevac N.V.于2025年7月1日跌0.37%，报5.41美元，该股过去5个交易日涨0.93%，年初至今涨58.65%，过去60日涨90.49%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702094252a4c9fc80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702094252a4c9fc80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","GSK.UK","CVAC","GSK","BK4588","BK4548","BK4139","LU1829250122.USD","BK4585","BK4551","BK4007"],"gpt_icon":0},{"id":"2546773327","title":"Curevac N.V.6月27日成交额为414.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546773327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546773327?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:43","pubTimestamp":1751075001,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Curevac N.V.成交额为414.03万美元，成交额较昨日减少4.82%，当日成交量为77.07万股。Curevac N.V.于2025年6月27日跌0.37%，报5.38美元，该股过去5个交易日跌1.1%，年初至今涨57.77%，过去60日涨97.79%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628094330a4c238ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628094330a4c238ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","GSK.UK","CVAC","GSK","BK4588","BK4548","BK4139","LU1829250122.USD","BK4585","BK4551","BK4007"],"gpt_icon":0},{"id":"2546473772","title":"瑞银：下调CureVac(CVAC.US)评级，由买入调整至中性评级, 目标价由12.00美元调整至5.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546473772","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546473772?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:31","pubTimestamp":1750951889,"startTime":"0","endTime":"0","summary":"瑞银：下调CureVac(CVAC.US)评级，由买入调整至中性评级, 目标价由12.00美元调整至5.50美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/26233151332050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CVAC"],"gpt_icon":0},{"id":"2546527538","title":"Curevac N.V.6月25日成交额为600.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546527538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546527538?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:43","pubTimestamp":1750902230,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日，Curevac N.V.成交额为600.17万美元，成交额较昨日增加83.59%，当日成交量为111.58万股。Curevac N.V.于2025年6月25日涨1.49%，报5.44美元，该股过去5个交易日跌1.09%，年初至今涨59.53%，过去60日涨82.55%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094355a4be3f19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094355a4be3f19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GSK.UK","BK4551","BK4548","LU1829250122.USD","BK4588","BK4585","GSK","BK4532","BK4007","CVAC","BK4139"],"gpt_icon":0},{"id":"2546268577","title":"Curevac N.V.6月24日成交额为326.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546268577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546268577?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:41","pubTimestamp":1750815705,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Curevac N.V.成交额为326.91万美元，成交额较昨日减少20.62%，当日成交量为60.89万股。Curevac N.V.于2025年6月24日跌0.65%，报5.36美元，该股过去5个交易日跌2.9%，年初至今涨57.18%，过去60日涨91.43%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625094147a4bc61ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625094147a4bc61ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","GSK","BK4139","BK4588","BK4532","GSK.UK","BK4007","LU1829250122.USD","BK4551","CVAC","BK4548"],"gpt_icon":0},{"id":"2545422101","title":"Curevac N.V.6月23日成交额为411.85万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545422101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545422101?lang=zh_cn&edition=full","pubTime":"2025-06-24 09:41","pubTimestamp":1750729282,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日，Curevac N.V.成交额为411.85万美元，成交额较昨日减少63.13%，当日成交量为76.39万股。Curevac N.V.于2025年6月23日跌0.83%，报5.4美元，该股过去5个交易日跌3.14%，年初至今涨58.21%，过去60日涨89.3%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624094128a4ba82d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624094128a4ba82d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","CVAC","BK4532","GSK.UK","BK4548","LU1829250122.USD","BK4139","GSK","BK4588","BK4007","BK4585"],"gpt_icon":0},{"id":"2545109043","title":"Curevac N.V.6月20日成交额为1117.08万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545109043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545109043?lang=zh_cn&edition=full","pubTime":"2025-06-21 09:42","pubTimestamp":1750470124,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日，Curevac N.V.成交额为1117.08万美元，成交额较昨日增加101.50%，当日成交量为204.39万股。Curevac N.V.于2025年6月20日跌0.91%，报5.44美元，该股过去5个交易日跌2.86%，年初至今涨59.53%，过去60日涨86.94%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621094205a4b58e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621094205a4b58e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4139","CVAC","BK4007","GSK","GSK.UK","BK4588","LU1829250122.USD","BK4551","BK4585","BK4532"],"gpt_icon":0},{"id":"2543514096","title":"Curevac N.V.6月13日成交额为2674.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543514096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543514096?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:42","pubTimestamp":1749865355,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日，Curevac N.V.成交额为2674.78万美元，成交额较昨日减少78.92%，当日成交量为483.49万股。Curevac N.V.于2025年6月13日跌0.54%，报5.57美元，该股过去5个交易日涨26.3%，年初至今涨63.34%，过去60日涨83.22%。该公司成立于2000年，并于2020年8月进行了首次公开募股。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614094237a7089015&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614094237a7089015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4139","BK4548","CVAC"],"gpt_icon":0},{"id":"1114205489","title":"美股异动 | 生物科技公司CureVac涨幅扩大至37%，获BioNTech以12.5亿美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1114205489","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114205489?lang=zh_cn&edition=full","pubTime":"2025-06-12 22:24","pubTimestamp":1749738265,"startTime":"0","endTime":"0","summary":"BioNTech将以12.5亿美元收购CureVac。","market":"us","thumbnail":"https://static.tigerbbs.com/a73bfb76c91f80045aa7a80f79e0786b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a73bfb76c91f80045aa7a80f79e0786b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4868bc7389eb9be96f392fda68b1dfce","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVAC"],"gpt_icon":0},{"id":"2542517366","title":"Curevac N.V.盘中异动 早盘股价大涨32.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542517366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542517366?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:32","pubTimestamp":1749735167,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时32分，Curevac N.V.股票出现波动，股价急速拉升32.92%。截至发稿，该股报5.41美元/股，成交量791.495万股，换手率3.52%，振幅3.19%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.23%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612213247a7056878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"3027c44315e197be94df144e6d65b09b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612213247a7056878&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","CVAC","BK4139","BK4551"],"gpt_icon":0},{"id":"1198330535","title":"异动解读 | CureVac盘前大涨28.99%，BioNTech拟12.5亿美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1198330535","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198330535?lang=zh_cn&edition=full","pubTime":"2025-06-12 19:06","pubTimestamp":1749726397,"startTime":"0","endTime":"0","summary":"生物科技公司CureVac B.V.今日盘前大涨28.99%，引发市场高度关注。根据最新消息，德国生物科技巨头BioNTech计划以12.5亿美元收购CureVac，此举旨在增强BioNTech的癌症业务。这一收购消息成为推动CureVac股价大幅上涨的主要原因。此次收购对双方都具有重要意义。对BioNTech而言，收购CureVac将有助于其扩大在癌症治疗领域的布局，进一步增强其在生物科技行业的竞争力。对CureVac来说，被行业巨头收购不仅能为公司带来可观的溢价，还可能为其研发项目提供更多资源和支持。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3027c44315e197be94df144e6d65b09b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"异动解读 | CureVac盘前大涨28.99%，BioNTech拟12.5亿美元收购","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CVAC"],"gpt_icon":0},{"id":"2542341933","title":"Curevac N.V.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542341933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542341933?lang=zh_cn&edition=full","pubTime":"2025-06-11 00:46","pubTimestamp":1749573985,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日00时46分，Curevac N.V.股票出现波动，股价大幅下挫5.13%。截至发稿，该股报4.25美元/股，成交量36.7518万股，换手率0.16%，振幅5.58%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.73%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611004625a4a239ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611004625a4a239ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4548","CVAC","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.curevac.com","stockEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":-0.0543},{"period":"3month","weight":-0.0543},{"period":"6month","weight":-0.0934},{"period":"1year","weight":0.5781},{"period":"ytd","weight":0.4809}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Curevac N.V.于2020年4月7日根据荷兰法律注册成立。该公司是一家全球性的临床阶段生物制药公司，开发基于信使核糖核酸的新型转化药物，该药物具有改善人们生活的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.081893},{"month":2,"riseRate":0.2,"avgChangeRate":-0.099557},{"month":3,"riseRate":0.2,"avgChangeRate":-0.055603},{"month":4,"riseRate":0.6,"avgChangeRate":0.064149},{"month":5,"riseRate":0.8,"avgChangeRate":0.233107},{"month":6,"riseRate":0.4,"avgChangeRate":-0.089668},{"month":7,"riseRate":0.2,"avgChangeRate":-0.076476},{"month":8,"riseRate":0.2,"avgChangeRate":-0.023047},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.136579},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.099323},{"month":11,"riseRate":0.833333,"avgChangeRate":0.241614},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.133044}],"exchange":"NASDAQ","name":"CureVac B.V.","nameEN":"CureVac B.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CureVac B.V.,CVAC,CureVac B.V.股票,CureVac B.V.股票老虎,CureVac B.V.股票老虎国际,CureVac B.V.行情,CureVac B.V.股票行情,CureVac B.V.股价,CureVac B.V.股市,CureVac B.V.股票价格,CureVac B.V.股票交易,CureVac B.V.股票购买,CureVac B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}